Teresa M. Cardesa‐Salzmann

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Gonzalo Gutiérrez, Teresa M. Cardesa‐Salzmann, Fina Climent et al. · Blood · 2011 · 319 citations · Full text

Medicine, Immunology, Oncology +16

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Alexandra Valera, Armando López‐Guillermo, Teresa M. Cardesa‐Salzmann et al. · Haematologica · 2013 · 227 citations · Full text

Medicine, Genetics, Oncology +14

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Teresa M. Cardesa‐Salzmann, Lluı́s Colomo, Gonzalo Gutiérrez et al. · Haematologica · 2011 · 130 citations · Full text

Medicine, Oncology, Pathology +17

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

Anamarija M. Perry, Teresa M. Cardesa‐Salzmann, Paul N. Meyer et al. · Blood · 2012 · 62 citations · Full text

Medicine, Oncology, Pathology +16

Congenital cervical neuroblastoma

Teresa M. Cardesa‐Salzmann, Jaume Mora, Gemma Claret Teruel et al. · Pediatric Blood & Cancer · 2004 · 35 citations

Medicine, Oncology, Cervical Disease +9